No takes yet. Share an insight, caveat, or question.
Cross-sectional analysis reveals high isoniazid resistance rates exceeding rifampicin resistance in tuberculosis patients, highlighting the need for improved molecular diagnostics.
Dean et al. (2020) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: